Lynn E. DeLisi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lynn E. DeLisi has a total of 237 co-authors. Here are the top co-authors by number of shared publications:
- Amelia T Nasrallah
Professor of Psychiatry & Neuroscience Department of Psychiatry and Behavioral Neuroscience University of Cincinnati College of Medicine PO Box 670559 45267-0559 Cincinnati OH USA
3 shared publications Andrea M. Maurizio
The Department of Psychiatry New York University, New York, New York
3 shared publicationsChristine Svetina
The Department of Psychiatry New York University, New York, New York
3 shared publications- Henry A. Nasrallah
Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH
3 shared publications Kamran Razi
3 shared publicationsTimothy J. Crow
The SANE—Prince of Wales International Centre (POWIC) at The Warneford Hospital, Oxford University, Headington, UK
3 shared publications
Latest Publications
- 27 March 2025
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 38 (3) , 145-146
How and why scientific discoveries and clinical innovations are published
- 27 March 2025
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 38 (3) , 145-146
How and why scientific discoveries and clinical innovations are published
- 1 May 2019
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 32 (3) , 145-146
Editorial
Aging researchers Lynn DeLisi; Current Opinion in Psychiatry
- 1 May 2019
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 32 (3) , 145-146
Editorial
Aging researchers Lynn DeLisi; Current Opinion in Psychiatry
- 1 January 2019
- Published by Elsevier in Psychiatry Research
- Vol. 271, A1
Moving on toward the 3rd decade of the 21st century
- 1 January 2019
- Published by Elsevier in Psychiatry Research
- Vol. 271, A1
Moving on toward the 3rd decade of the 21st century
- 1 May 2017
- Published by Elsevier in Schizophrenia Research
- Vol. 183, 1
In This Issue…
- 2 September 2016
- Published by Springer Nature
- p. 3-10
Lynn E. DeLisi
- Open Access
Quantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders
Genome-wide association studies of schizophrenia encompassing the major histocompatibility locus (MHC) were highly significant following genome-wide correction. This broad region implicates many genes including the MHC complex class II. Within this interval we examined the expression of two MHC II genes (HLA-DPA1 and HLA-DRB1) in brain from individual subjects with schizophrenia (SZ), bipolar disorder (BD), major depressive disorder (MDD), and controls by differential gene expression methods. A third MHC II mRNA, CD74, was studied outside of the MHC II locus, as it interacts within the same immune complex. Exon microarrays were performed in anterior cingulate cortex (ACC) in BD compared to controls, and both HLA-DPA1 and CD74 were decreased in expression in BD. The expression of HLA-DPA1 and CD74 were both reduced in hippocampus, amygdala, and dorsolateral prefrontal cortex regions in SZ and BD compared to controls by specific qPCR assay. We found several novel HLA-DPA1 mRNA variants spanning HLA-DPA1 exons 2-3-4 as suggested by exon microarrays. The intronic rs9277341 SNP was a significant cis expression quantitative trait locus (eQTL) that was associated with the total expression of HLA-DPA1 in five brain regions. A biomarker study of MHC II mRNAs was conducted in SZ, BD, MDD, and control lymphoblastic cell lines (LCL) by qPCR assay of 87 subjects. There was significantly decreased expression of HLA-DPA1 and CD74 in BD, and trends for reductions in SZ in LCLs. The discovery of multiple splicing variants in brain for HLA-DPA1 is important as the HLA-DPA1 gene is highly conserved, there are no reported splicing variants, and the functions in brain are unknown. Future work on the function and localization of MHC Class II proteins in brain will help to understand the role of alterations in neuropsychiatric disorders. The HLA-DPA1 eQTL is located within a large linkage disequilibrium block that has an irrefutable association with schizophrenia. Future tests in a larger cohort are needed to determine the significance of this eQTL association with schizophrenia. Our findings support the long-held hypothesis that alterations in immune function are associated with the pathophysiology of psychiatric disorders.
Open AccessQuantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders
Genome-wide association studies of schizophrenia encompassing the major histocompatibility locus (MHC) were highly significant following genome-wide correction. This broad region implicates many genes including the MHC complex class II. Within this interval we examined the expression of two MHC II genes (HLA-DPA1 and HLA-DRB1) in brain from individual subjects with schizophrenia (SZ), bipolar disorder (BD), major depressive disorder (MDD), and controls by differential gene expression methods. A third MHC II mRNA, CD74, was studied outside of the MHC II locus, as it interacts within the same immune complex. Exon microarrays were performed in anterior cingulate cortex (ACC) in BD compared to controls, and both HLA-DPA1 and CD74 were decreased in expression in BD. The expression of HLA-DPA1 and CD74 were both reduced in hippocampus, amygdala, and dorsolateral prefrontal cortex regions in SZ and BD compared to controls by specific qPCR assay. We found several novel HLA-DPA1 mRNA variants spanning HLA-DPA1 exons 2-3-4 as suggested by exon microarrays. The intronic rs9277341 SNP was a significant cis expression quantitative trait locus (eQTL) that was associated with the total expression of HLA-DPA1 in five brain regions. A biomarker study of MHC II mRNAs was conducted in SZ, BD, MDD, and control lymphoblastic cell lines (LCL) by qPCR assay of 87 subjects. There was significantly decreased expression of HLA-DPA1 and CD74 in BD, and trends for reductions in SZ in LCLs. The discovery of multiple splicing variants in brain for HLA-DPA1 is important as the HLA-DPA1 gene is highly conserved, there are no reported splicing variants, and the functions in brain are unknown. Future work on the function and localization of MHC Class II proteins in brain will help to understand the role of alterations in neuropsychiatric disorders. The HLA-DPA1 eQTL is located within a large linkage disequilibrium block that has an irrefutable association with schizophrenia. Future tests in a larger cohort are needed to determine the significance of this eQTL association with schizophrenia. Our findings support the long-held hypothesis that alterations in immune function are associated with the pathophysiology of psychiatric disorders.
- Open Access
- 31 December 2014
- Published by Taylor & Francis in Dialogues in clinical neuroscience
- Vol. 16 (4) , 447-450
Pursuit of the “truth” about mental illness: the significance of findings in neuropsychiatric research, and lessons from the past
Technology in genetics and brain imaging has advanced so rapidly that it is difficult to be knowledgeable about all the new tools being used in the pursuit of progress toward understanding and treating mental illness. While findings from new studies remain promising, caution is needed with regard to …
- 31 December 2014
- Published by Taylor & Francis in Dialogues in clinical neuroscience
- Vol. 16 (4) , 447-450
Open AccessPursuit of the “truth” about mental illness: the significance of findings in neuropsychiatric research, and lessons from the past
Technology in genetics and brain imaging has advanced so rapidly that it is difficult to be knowledgeable about all the new tools being used in the pursuit of progress toward understanding and treating mental illness. While findings from new studies remain promising, caution is needed with regard to …
- 1 March 2013
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 26 (2) , 137
Encouraging a new generation of researchers in a time of limited resources
- 1 March 2013
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 26 (2) , 137
Encouraging a new generation of researchers in a time of limited resources
- 22 January 2013
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 162 (2) , 96-121
Selected rapporteur summaries from the XX world congress of psychiatric genetics, Hamburg, Germany, october 14-18, 2012
The XXth World Congress of Psychiatric Genetics (WCPG), sponsored by The International Society of Psychiatric Genetics (ISPG) took place in Hamburg, Germany on October 14-18, 2012. Approximately 600 participants gathered to discuss the latest findings in this rapidly advancing field. The following report was written by student travel awardees. Each was assigned sessions as rapporteurs. This manuscript represents topics covered in most, but not all, oral presentations during the conference, and some of the major notable new findings reported at this 2012 WCPG.
- 22 January 2013
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 162 (2) , 96-121
Selected rapporteur summaries from the XX world congress of psychiatric genetics, Hamburg, Germany, october 14-18, 2012
The XXth World Congress of Psychiatric Genetics (WCPG), sponsored by The International Society of Psychiatric Genetics (ISPG) took place in Hamburg, Germany on October 14-18, 2012. Approximately 600 participants gathered to discuss the latest findings in this rapidly advancing field. The following report was written by student travel awardees. Each was assigned sessions as rapporteurs. This manuscript represents topics covered in most, but not all, oral presentations during the conference, and some of the major notable new findings reported at this 2012 WCPG.